Translating Science for a Healthier North Serum anti-VacA IgG and IgA antibodies as markers of H. pylori infection and disease progression Northern Health.

Slides:



Advertisements
Similar presentations
Global Health Estimates: Key figures and tables
Advertisements

Health Statistics and Informatics Global Burden of Disease 2004 Update: Selected figures and tables Health Statistics and Informatics Department.
GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
Burden of Communicable, Maternal and Perinatal Diseases in Gansu, China Wangxi Hai Northwest University for Nationalities West of China Institute of Environment.
CHILDHOOD INJURY PREVENTION CONFERENCE1. Child Pedestrian Injuries: A Global Problem Priti Gautam Thursday, June 20 2.
Protein GP73 (GOLGI PROTEIN 73) A NEW NON-INVASIVE BIOMARKER FOR ASSESSING LIVER FIBROSIS AND RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA N.K. Gatselis,
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
Cardiovascular System II. How do we measure blood pressure ?
Population Perspective of Relations Individual Family Community, nation Human population All populations.
Deaths due to Road Traffic Crashes by Age-group
Introduction to Public Health January 29,
Epidemic of Cardiovascular disease Global and US trends Any Lessons for Honduras? Dr. Thomas G. Allison Cardiovascular Diseases and Internal Medicine Mayo.
Ten Leading Causes of Death. Name the 10 leading causes of death and rank them in order from greatest to least. Name the 10 leading causes of death and.
Injury Epidemiology An Introduction readings Thomas Songer, PhD University of Pittsburgh.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Cancer Worldwide September 2011.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.
Injuries and violence: the global magnitude Etienne Krug Director, Violence and Injury Prevention and Disability World Health Organization.
Determining the burden of hip/knee osteoarthritis and rheumatoid arthritis using disability-adjusted life-years (DALYs) United States, 1996 Arthritis Program.
National Institutes of Health
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Combating disease and improving health Presented by ROSANNA AGBLE at Taking Action for the World’s Poor and Hungry People Beijing, China October 17–19,
Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.
Public Health. CVDDiabetesCancer Antibiotic Resistance.
Comparison of the American and Australian Health Care Systems By Emma Dougall, Emily Josef, Christie Felber and Hamed Al - Yahmedy.
Introduction to the Fundamentals of Epidemiology Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Injuries and Violence Prevention: WHO's approach Injuries and Violence Prevention: WHO's approach Etienne Krug, MD, MPH Director, Department of Injuries.
Ageing and vulnerability in ASEAN countries Eduardo Klien 5 th ASEAN GO-NGO Forum, 22 November 2010, Brunei Darussalam.
New topic. Global Patterns of Disease The aim of this lesson: To describe and explain the global distribution of diseases of poverty. To describe and.
Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute.
Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.
Joseph Perriëns MD, PhD Dept of HIV/AIDS World Health Organization
INJURY EPIDEMIOLOGY & PREVENTION. Definitions Injury “Acute exposure to physical agents such as mechanical energy, heat, electricity, chemicals, and ionising.
The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.
WORLD HEALTH ORGANIZATION Source: World Health Report 2000 JS 3/01 WHO Statistics, 2000 Dr. Rüdiger Krech A/Regional Adviser, Healthy Ageing World Health.
The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.
Driving non-regulated vehicles for work – cars & vans M. O’Malley 30/01/13.
Similarities and differences between developing countries and Australia Chapter 8.2.
Geriatric education for PHC physicians – 1 st congress of the EU Geriatric Medicine society Paris, August 29 th -Sept.1 st, 2001 Dr. Rüdiger Krech A/Regional.
The Good…. The Bad…. & The Ugly.. Disease concepts  How many diseases are there?  Health, Function, Disability, Impairment, oh my!  Is it a disease.
The Medical Research Council Presentation to the Portfolio Committee on Science and Technology March 16, 2005
Health Outcomes due to Alcohol 14 July 2005 Kanitta Bundhamcharoen MOPH.
UNIT I. What are the causes and nature of adult death locally, nationally and globally and how can these factors be reduced? What are the factors that.
Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.
Maintaining Healthy Systems. The 10 leading causes of death (WHO, 2008) World Deaths in millions % of deaths Ischaemic heart disease % Stroke and.
The Global Burden of Injuries Thomas Songer, PhD University of Pittsburgh.
Ways to Prevent Disease By Beth Goodrum 5 Leading Causes of Death in the US Heart Disease Cancer Chronic Lower Respiratory Disease Stroke Unintentional.
Environmental Health and Toxicology Introductory Lecture.
Spatial Health Analysis Click to continue. A series of sketch maps and charts are used to present a selection of well-recognised health patterns. These.
World Health Organization
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Cardiovascular Risk: A global perspective
GI For Rehabilitation.
BASIC HEALTH INDICATORS CHANGES AFTER NATURAL DISASTER
Global disability-adjusted life-years (DALYs) for Global Burden of Disease level three causes from Within this tree map, the size of the rectangle.
Relationship between CMV & PU disease
Hypertension Update: How Low Shall We Go?
DYSLIPIDEMIA AND ATHEROSCLEROSIS
The Leading Causes of Mortality
Please sit in groups of THREE today.
Amnon Sonnenberg, Richard H. Lash, Robert M. Genta  Gastroenterology 
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Impact of metabolic risk factors on HCC
WHO Statistics, 2000 Dr. Rüdiger Krech
Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.
Why people get diseases?
WELCOME TO THE CME ON “CURRENT CONCEPTS IN THE MANAGEMENT OF COPD”
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Trends of mortality rates in the USA between 1930 and 2000 in males according to cancer site. –––––: stomach; ·······: prostate; –– –– ––: colon and rectum;
Presentation transcript:

Translating Science for a Healthier North Serum anti-VacA IgG and IgA antibodies as markers of H. pylori infection and disease progression Northern Health Research Conference 2015 Dr. Elizabeth Acosta-Ramirez

Conflict of Interest Declaration: Nothing to Disclose Presenter: Elizabeth Acosta-Ramirez, PhD Serum anti-VacA IgG and IgA antibodies as markers of H. pylori infection and disease progression Title of Presentation: Serum anti-VacA IgG and IgA antibodies as markers of H. pylori infection and disease progression I have no financial or personal relationships to disclose

The affiliated research institute of: Translating Science for a Healthier North H. pylori infection

Prevalence of H. pylori infection in different countries within WHO Regions Region of the Americas European Region Western Pacific Region From: Dig Dis Sci Aug;59(8):

The affiliated research institute of: Translating Science for a Healthier North RANK Ischaemic heart disease 2Stroke 3Lower respiratory infectionsChronic obstructive pulmonary disease 4 Lower respiratory infections 5Diarrhoeal diseasesTrachea, bronchus, lung cancers 6HIV/AIDS 7TuberculosisDiarrhoeal diseases 8Preterm birth complicationsDiabetes mellitus 9Trachea, bronchus, lung cancersRoad injury 10Diabetes mellitusHypertensive heart disease 11Birth asphyxia and birth traumaPreterm birth complications 12Road injuryCirrhosis of the liver 13Cirrhosis of the liverTuberculosis 14Self-harmKidney diseases 15MalariaSelf-harm 16Hypertensive heart diseaseBirth asphyxia and birth trauma 17Kidney diseasesLiver cancer 18 Stomach cancer 19MeaslesColon and rectum cancers 20Congenital anomaliesAlzheimer’s disease and other dementias Top 20 causes of death worldwide 2000 & 2012 WHO Report

The affiliated research institute of: Translating Science for a Healthier North Gastric cancer mortality demographics WHO Report

The affiliated research institute of: Translating Science for a Healthier North Global H. pylori antibiotic resistance Gastroenterol Res Pract. 2012;2012:723183

The affiliated research institute of: Translating Science for a Healthier North Distribution of H. pylori genotypes before Columbus found the New world and human migration to America and Oceania began Nat. Rev. Gastroenterol. Hepatol

H. pylori The affiliated research institute of: Translating Science for a Healthier North

The affiliated research institute of: Translating Science for a Healthier North Is there a marker that can be used to identify patients infected with H. pylori that have increased susceptibility to develop gastric cancer?

Study volunteers The affiliated research institute of: Translating Science for a Healthier North

Distribution of H. pylori in patients from HSN The affiliated research institute of: Translating Science for a Healthier North FEMALES PATIENT ID#HISTOLOGYCULTURE HP 011√√ HP 060√√ HP 066√√ HP 068√√ HP 079√√ HP 103√√ HP 120*√ HP 163√√ HP 172** √ HP 173** √ HP 181√√ HP 193*√ HP 209** √ HP 217*√ HP 225** √ HP 233√√ HP 240√√ HP 290√√ MALES PATIENT ID#HISTOLOGYCULTURE HP 017** √ HP 045** √ HP 063√√ HP 076*√ HP 104√√ HP 110√√ HP 170√√ HP 195√√ HP 207√√ HP 227** √ HP 236** √ HP 239√√ HP 243√√ HP 263√√ HP 283√√ HP 288√√ HP 299** √ FMTotal Histology141226/301 Culture151631/301

Serum IgG and IgA anti-H. pylori antibody response correlates with severity of gastric mucosa pathology The affiliated research institute of: Translating Science for a Healthier North

Serum IgG and IgA anti-H. pylori antibody response correlates with severity of gastric mucosa pathology The affiliated research institute of: Translating Science for a Healthier North Intestinal metaplasia Reactive gastropathy Adenocarcinoma Chronic gastritisMild chronic gastritis Focal intestinal metaplasia No active inflammation

H. pylori incidence The affiliated research institute of: Translating Science for a Healthier North

Genome sequencing The affiliated research institute of: Translating Science for a Healthier North with serum sampleall clinical isolates GENOTYPEFEMALESMALESTOTALFEMALESMALESTOTAL cagA+vacA ( 23.53% ) 53 8 ( 25.81% ) cagA-vacA ( 76.47% ) ( 74.19% ) TOTAL ( 100% ) ( 100% )

Conclusion The affiliated research institute of: Translating Science for a Healthier North We found that histological analysis, culturing and VacA serology studies combined to not only better diagnose H. pylori infection, but also to predict which patients have increased risk to develop gastric cancer.

Acknowledgements The affiliated research institute of: Translating Science for a Healthier North  Dr. Francisco Diaz-Mitoma  Katrina Chapman, B. Sc.  Dr. Gustavo Ybazeta  Dr. Nelson Eng  HSN  Department Pathology  Department Gastroenterology Funding: NOAMA